• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
710.40 -2 (-0.25%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    701.00

  • Today’s High

    715.95

  • Open

    715.95

  • Perv Close

    712.15

  • 52W Low

    603.80

  • 52W High

    1,997.40

Key Indicators

  • P/E(TTM)

    33.83

  • Mar.Cap (₹Cr.)

    3,603.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    261.06

  • Debt-Equity Ratio

    -0.25

  • AGM Date

    25-Jul-2025

  • EPS

    20.99

  • P/E Ratio

    33.83

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    3,603.09

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    50.72

  • BV (₹)

    261.10

  • Sales( ₹ in Cr.)

    921.93

  • NP (in Cr.)

    106.48

  • NP Var(%)

    12.0

  • Div%

    0.0

  • CPS (₹)

    27.80

  • EPS (₹)

    21.00

  • Traded Value (₹ in Lakhs)

    3,601.06

  • 52 Week High

    1,997.40

  • 52 Week Low

    603.80

  • Price BSE

    710.0

  • Price NSE

    710.00

  • Market Capital( in Cr.)

    3,601.06

  • P/C Ratio

    25.60

  • P/E Ratio

    33.80

  • Price Vs.BV

    21.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 819.37 665.90 556.97 450.70 481.21 583.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 819.37 665.90 556.97 450.70 481.21 583.65
Other Income 30.39 58.64 56.97 6.46 24.28 217.86
Stock Adjustments 43.89 21.48 22.73 15.69 20.07 -20.43
Total Income 893.65 746.02 636.67 472.85 525.56 781.08
EXPENDITURE :            
Raw Materials 528.35 406.10 336.80 244.96 220.38 257.73
Power and Fuel Cost 62.92 61.26 52.74 39.31 47.44 48.76
Employee Cost 69.64 65.35 60.21 64.40 71.60 79.14
Other Manufacturing Expenses 32.65 29.19 26.26 24.26 40.77 41.85
Selling and Administration Expenses 53.17 34.96 37.77 31.58 58.78 48.39
Miscellaneous Expenses 5.46 7.28 7.22 24.38 112.29 269.63
Employee Benefit Expenses 69.64 65.35 60.21 64.40 71.60 79.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 752.20 604.14 521.00 428.89 551.26 745.51
Operating Profit 141.45 141.88 115.67 43.96 -25.71 35.55
Interest 16.71 32.90 33.46 52.21 6.22 6.68
Gross Profit 124.74 108.98 82.21 -8.25 -31.93 28.87
Depreciation 33.22 54.79 87.02 108.90 117.91 129.92
Profit Before Tax 91.52 54.19 -4.81 -117.15 -149.84 -101.05
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -3.23 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 94.75 54.19 -4.81 -117.15 -149.84 -101.05
Extraordinary Items -0.19 40.00 0.51 0.98 0.09 24.94
Adjusted Net Profit 94.94 14.19 -5.32 -118.13 -149.93 -125.99
Adjustment below Net Profit 0.00 0.00 0.00 0.00 88.56 0.00
P & L Balance brought forward -2,082.68 -2,136.64 -2,133.29 -2,016.74 -1,953.57 -1,853.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.45 0.23 -1.46 -0.60 1.89 -0.90
P & L Balance carried down -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74 -1,953.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 18.68 13.28 -1.18 -28.70 -36.71 -11.36
Earnings Per Share(Adj)-Unit Curr 18.68 13.28 -1.18 -28.70 - -11.36
Book Value 226.69 162.53 149.30 150.13 178.67 -84.86
Book Value(Adj)-Unit Curr 226.69 162.53 149.30 150.13 - -84.86

Shareholding Pattern

  • Promoter Group

    69.84%

  • Public Share Holding

    30.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,419,957 69.84 35,419,957 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,419,957 69.84 35,419,957 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.06 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 709,017 1.40 709,017 36
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,219 0.14 70,219 3
Mutual Funds / UTI 9,421,595 18.58 9,421,595 14
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 328,948 0.65 328,948 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,562,219 20.82 10,562,219 60
2] Non Institution
Bodies Corporate 753,803 1.49 750,565 375
Clearing Members 28 0.00 28 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 213,495 0.42 213,495 676
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 140,167 0.28 140,167 1,027
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 481,399 0.95 481,399 14
Individuals holding nominal share capital up to Rs. 1 lakh 3,023,355 5.96 3,023,081 37,663
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 123,978 0.24 123,978 3
Others 636 0.00 636 3
Sub Total 4,736,929 9.34 4,733,417 39,766
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,719,105 100.00 50,715,593 39,827

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    Ram Gopal Agarwal

  • Managing Director

    Manish Dhanuka

  • Company Secretary

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 710.00 849.76 819.37 33.83 3.33
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10